Brittany Parker Kerrigan

Brittany earned her biology degree from UC Irvine and began her career as an industry scientist at Allergan. She completed a Ph.D. in neuroscience at the University of Texas MD Anderson Cancer Center, where her dissertation characterized the first recurrent gene found in glioblastoma, FGFR3-TACC3. As a T32 fellow between Rice University and MD Anderson, she focused on translational therapeutics for FGFR3-TACC3+ patients. Recognizing her strengths in leadership and strategy, she transitioned into scientific administration as Director of Cancer Neuroscience at MD Anderson. She was later recruited to Lindonlight Collective to build and manage a $100M global research portfolio advancing pediatric brain cancer diagnostics and therapeutics. At DFCI, she leads strategic operations for the PLGA Program, coordinating efforts across the institute and international collaborators.

Fun fact: As a mom to three young sons, Brittany is intent on instilling a “do-it-yourself with a sense of urgency” mindset, and believes she was a Navy Seal in her past life. When she’s not working, practicing baseball, fishing with her sons, or buying the newest power tool at Home Depot, you can find her landscaping, digging trenches, refinishing furniture, power washing, or detailing her car.

Favorite quote: “Be the reason someone believes in the goodness of people.” -Karen Salmansohn